tiprankstipranks
Trending News
More News >
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
US Market
Advertisement

Claritas Pharmaceuticals (CLAZF) Income Statement

Compare
24 Followers

Claritas Pharmaceuticals Income Statement

Last quarter (Q3 2021), Claritas Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Claritas Pharmaceuticals's net income was $181.00K. See Claritas Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 20Dec 19Dec 18Dec 17Dec 16
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -18.89K
Operating Expenses
$ -184.00K$ 9.45M$ 11.10M$ 4.92M$ 5.07M
Depreciation and Amortization
$ -184.00K$ 9.45M$ 11.10M$ 19.00K$ 18.89K
EBITDA
$ -2.79M$ -16.72M$ 18.14M$ -15.44M$ -11.40M
Operating Income
$ -3.28M$ -9.45M$ -4.59M$ -14.50M$ -12.00M
Other Income/Expenses
$ 3.25M$ -16.13M$ 17.94M$ -27.06M$ -6.48M
Pretax Income
$ -674.00K$ -25.83M$ 6.84M$ -31.86M$ -11.55M
Net Income
$ 4.21M$ -21.21M$ 6.93M$ -31.86M$ -11.55M
Per Share Metrics
Basic EPS
$ 0.16$ -0.95$ 0.64$ -5.13$ -7.86
Diluted EPS
$ 0.16$ -1.00$ 0.64$ -5.13$ -7.86
Weighted Average Shares Outstanding
26.69M 22.44M 10.92M 6.21M 1.47M
Weighted Average Shares Outstanding (Diluted)
26.69M 22.44M 10.92M 6.21M 1.47M
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis